For Type 2 Diabetes Poorly Controlled by Metformin Monotherapy, the Addition of Any Non-Insulin Antidiabetic Drug Reduces HbA1c to a Similar Extent, but With Differing Effects on Weight and Hypoglycaemic Risk
Evidence-Based Medicine - United Kingdom
doi 10.1136/ebm1116
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 21, 2011
Authors
Publisher
BMJ